文献速递头颈外科咽喉与嗓音

cT4a期喉鳞状细胞癌手术与放化疗生存差异的倾向评分匹配分析

Differences in Survival Following Surgery Versus Chemoradiotherapy for Clinical Stage T4a Laryngeal Squamous Cell Carcinoma: A Propensity Score-Matched Analysis.
PubMed 文献 · Head Neck · 2025-12-16

基于美国国家癌症数据库2010—2021年cT4a期喉鳞状细胞癌患者的回顾性队列,经1:1倾向评分匹配后比较根治性手术与放化疗的总生存。匹配队列每组452例,手术组中位生存52.8个月,放化疗组37.6个月,放化疗相对手术的校正HR为1.26(95%CI 1.02-1.57),提示手术与更优总生存相关。

要点

  • cT4a期喉鳞癌手术组中位生存52.8个月,放化疗组37.6个月
  • 匹配后放化疗相对手术的校正HR为1.26(95%CI 1.02-1.57)
  • 手术与cT4a期喉鳞癌更优总生存相关

核心结论

  • 在cT4a期喉鳞状细胞癌患者中,手术与相比根治性放化疗更优的总生存相关。

研究设计与样本

  • 回顾性队列研究,使用美国国家癌症数据库2010—2021年接受根治性手术或放化疗的cT4a期喉鳞状细胞癌患者。
  • 排除接受新辅助或姑息治疗以及存在远处转移者,共纳入3569例(平均年龄61.0岁,708例女性)。
  • 生存分析采用Kaplan-Meier法和Cox模型,并行1:1倾向评分匹配。

主要发现

  • 全队列中2437例(68.3%)接受手术,1132例(31.7%)接受放化疗。
  • 匹配队列每组452例,手术组中位生存52.8个月(95%CI 45.6-62.4),放化疗组37.6个月(95%CI 29.2-45.4)。
  • 放化疗相对手术的校正HR为1.26(95%CI 1.02-1.57)。

临床怎么用

  • 对于cT4a期喉鳞状细胞癌,在制定根治性方案时可考虑手术可能带来总生存获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although laryngeal cancer incidence has declined in the United States, case fatality has risen. The survival equivalence of surgery versus chemoradiotherapy (CRT) for cT4a laryngeal squamous cell carcinoma (LSCC) remains uncertain. METHODS: We conducted a retrospective cohort study of cT4a LSCC patients treated with curative-intent surgery or CRT using the National Cancer Database (2010-2021). Those receiving neoadjuvant or palliative therapy, or with distant metastases were excluded. Survival was assessed using Kaplan-Meier and Cox models after 1:1 propensity score matching. RESULTS: Among 3569 patients (mean age 61.0, 708 female), 2437 (68.3%) underwent surgery while 1132 (31.7%) received CRT. In the matched cohort (n = 452 per arm), median survival was 52.8 (95% CI: 45.6-62.4) versus 37.6 (95% CI: 29.2-45.4) months for surgery versus CRT. Adjusted HR for CRT relative to surgery was 1.26 (95% CI: 1.02-1.57). CONCLUSIONS: Surgery was associated with improved overall survival compared with definitive CRT in patients with T4a LSCC.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Fu BJ, Potter AL, Pipkorn P, et al. Differences in Survival Following Surgery Versus Chemoradiotherapy for Clinical Stage T4a Laryngeal Squamous Cell Carcinoma: A Propensity Score-Matched Analysis. Head Neck. 2025. PMID: 41403196. doi:10.1002/hed.70114

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。